Wellthy Therapeutics raises $4M

Digital therapeutics company Wellthy Therapeutics announced it has raised $4 million from Saama Capital as part of its pre-series A round for an almost 16% stake in the company. This round brings the company’s total funding to $7.6 million.

Established in 2015, the Indian company (and a team of ~90) designs clinically validated behavioral interventions for chronic disease management in South Asia. “We play the role of an on-demand nutritionist, educator, fitness coach and counselor, enabling patients to develop the skills they need to prevent, manage and even reverse their chronic conditions.”

Wellthy is known for its Diabetes Reversal Program that leverages AI  to help users manage their weight, and live a healthier, more active lifestyle. At one point the company conducted a clinical study that proved that in as little as 16 weeks, most patients saw improvements in blood sugar control, while reducing or eliminating medications, and lost weight.

Bottom Line: an enabler.